John Powderly, Alexander Spira, Shunsuke Kondo, Toshihiko Doi, Jason J. Luke, Drew Rasco, . . . Anthony Tolcher. (2021). Model Informed Dosing Regimen and Phase I Results of the Anti‐PD‐1 Antibody Budigalimab (ABBV‐181). Wiley.
Chicago Style (17th ed.) CitationJohn Powderly, et al. Model Informed Dosing Regimen and Phase I Results of the Anti‐PD‐1 Antibody Budigalimab (ABBV‐181). Wiley, 2021.
MLA (9th ed.) CitationJohn Powderly, et al. Model Informed Dosing Regimen and Phase I Results of the Anti‐PD‐1 Antibody Budigalimab (ABBV‐181). Wiley, 2021.
Warning: These citations may not always be 100% accurate.